Bionano Genomics, Inc. (BNGO) vs Femasys Inc. (FEMY)

Bionano Genomics, Inc. and Femasys Inc. are both Medical Instruments & Supplies companies. Bionano Genomics, Inc. and Femasys Inc. are of similar size ($20.4M and $19.9M). Femasys Inc. grew revenue faster over the last twelve months: 21.9% against 10.0%. Bionano Genomics, Inc. has the higher net margin (−106.6% vs −534.3%) and the higher return on invested capital (−81.7% vs −176.9%). Across the 18 metrics below, Bionano Genomics, Inc. leads on 14 and Femasys Inc. on 4.

Valuation

Metric BNGO FEMY Medical Instruments & Supplies median
P/E n/m n/m 34.17
P/S 0.64 3.62 2.83
P/B 0.61 2.07 2.82
Price to free cash flow n/m n/m 25.69
EV/EBITDA n/m n/m 16.08
EV/Sales 0.49 4.57 3.06
Earnings yield (180.84%) (142.34%) (1.84%)
Free cash flow yield (106.75%) (217.10%) 0.17%

Profitability

Metric BNGO FEMY Medical Instruments & Supplies median
Gross margin 47.51% 60.95% 54.62%
Operating margin (106.67%) (763.90%) 1.64%
Net margin (106.58%) (534.27%) 0.00%
Free cash flow margin (67.87%) (786.02%) 1.61%
Return on equity (83.56%) (443.65%) 0.00%
Return on assets (52.04%) (94.25%) 0.00%
Return on invested capital (81.68%) (176.91%) 0.00%

Growth

Metric BNGO FEMY Medical Instruments & Supplies median
Revenue growth (TTM) 10.03% 21.85% 9.20%
EPS growth (last fiscal year) 94.50% 44.71% —
Revenue growth, 5-year CAGR 27.37% 17.18% 9.48%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BNGO FEMY Medical Instruments & Supplies median
Debt to equity 0.11 0.90 0.08
Current ratio 2.48 2.14 2.49
Net debt to EBITDA 1.06 0.23 0.83

Dividend

Metric BNGO FEMY Medical Instruments & Supplies median
Dividend yield — — 0.99%
Payout ratio 0.00 0.00 0.00

Size

Metric BNGO FEMY Medical Instruments & Supplies median
Market cap 19.90m 20.35m 938.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack